Associations of public transport accessibility with walking, obesity, metabolic syndrome and diabetes

Alison Barr; Rebecca Bentley; Julie A Simpson; Jan Scheurer; Neville Owen; David Dunstan; Lukar Thornton; Lauren Krnjacki; Anne Kavanagh

Journal article

Associations of public transport accessibility with walking, obesity, metabolic syndrome and diabetes

Alison Barr, Rebecca Bentley, Julie A Simpson, Jan Scheurer, Neville Owen, David Dunstan, Lukar Thornton, Lauren Krnjacki, Anne Kavanagh

JOURNAL OF TRANSPORT & HEALTH | ELSEVIER SCI LTD | Published : 2016

DOI: 10.1016/j.jth.2016.01.006

University of Melbourne Researchers

Lauren Krnjacki Author Melbourne School of Population and Global Health

Ali Barr Author Melbourne School of Population and Global Health

Anne Kavanagh Author Melbourne School of Population and Global Health

Bec Bentley Author Melbourne School of Population and Global Health

Julie Simpson Author Melbourne School of Population and Global Health

Related Projects (2)

Understanding How Local And Regional Accessibility Are Associated With Active Travel, And Related Health And Economic Impacts.

Exercise and walking are vital for a healthy lifestyle and wellbeing. The accessibility and ’walkability’ of where one lives and works is ke..

Understanding How Local And Regional Accessibility Are Associated With Active Travel, And Related Health And Economic Impacts.

Exercise and walking are vital for a healthy lifestyle and wellbeing. The accessibility and ’walkability’ of where one lives and works is ke..

Grants

Awarded by National Health and Medical Research Council of Australia

Awarded by National Heart Foundation of Australia

Funding Acknowledgements

This research was funded by the National Health and Medical Research Council of Australia (Grant no. 324724) and the National Heart Foundation of Australia (Grant no. G07M3175). The AusDiab study was funded by the National Health and Medical Research Council of Australia (Grant no. 233200). The AusDiab study, co-coordinated by the Baker IDI Heart and Diabetes Institute, acknowledges support by the following: Australian Government Department of Health and Ageing, Abbott Australasia, Alphapharm, AstraZeneca, Aventis Pharma, Bristol-Myers Squibb, City Health Centre Diabetes Service Canberra, Diabetes Australia, Healthy Living NT, Eli Lilly Australia, Estate of the late Edward Wilson, GlaxoSmithKline, Jack Brockhoff Foundation, Janssen-Cilag, Kidney Health Australia, Marian & EH Flack Trust, Menzies Research Institute, Merck Sharp & Dohme, New South Wales Health, Northern Territory Department of Health and Families, Novartis, Novo Nordisk, Pfizer, Pratt Foundation, Queensland Health, Roche Diagnostics Australia, Royal Prince Alfred Hospital (Sydney), Sanofi-Synthelabo, South Australia Health, Tasmanian Department of Health and Human Services, Victorian Department of Human Services, and Western Australia Health.